- Home
- NVS vs HSBC Comparison
NVS vs HSBC Comparison
Compare NVS & HSBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVS
- HSBC
- Stock Information
- Founded
- NVS 1895
- HSBC 1865
- Country
- NVS Switzerland
- HSBC United Kingdom
- Employees
- NVS N/A
- HSBC N/A
- Industry
- NVS Biotechnology: Pharmaceutical Preparations
- HSBC Savings Institutions
- Sector
- NVS Health Care
- HSBC Finance
- Exchange
- NVS Nasdaq
- HSBC Nasdaq
- Market Cap
- NVS 242.8B
- HSBC 214.8B
- IPO Year
- NVS 1991
- HSBC N/A
- Fundamental
- Price
- NVS $116.93
- HSBC $63.79
- Analyst Decision
- NVS Hold
- HSBC Buy
- Analyst Count
- NVS 6
- HSBC 1
- Target Price
- NVS $123.67
- HSBC N/A
- AVG Volume (30 Days)
- NVS 2.1M
- HSBC 1.5M
- Earning Date
- NVS 07-17-2025
- HSBC 07-30-2025
- Dividend Yield
- NVS 2.24%
- HSBC 5.21%
- EPS Growth
- NVS N/A
- HSBC N/A
- EPS
- NVS 6.85
- HSBC 1.00
- Revenue
- NVS $55,186,000,000.00
- HSBC $56,208,000,000.00
- Revenue This Year
- NVS $8.96
- HSBC $10.40
- Revenue Next Year
- NVS $2.34
- HSBC $1.08
- P/E Ratio
- NVS $16.92
- HSBC $12.17
- Revenue Growth
- NVS 12.95
- HSBC N/A
- 52 Week Low
- NVS $96.06
- HSBC $40.73
- 52 Week High
- NVS $124.83
- HSBC $65.75
- Technical
- Relative Strength Index (RSI)
- NVS 47.75
- HSBC 54.13
- Support Level
- NVS $113.48
- HSBC $60.61
- Resistance Level
- NVS $118.38
- HSBC $63.30
- Average True Range (ATR)
- NVS 1.68
- HSBC 0.66
- MACD
- NVS -0.12
- HSBC -0.22
- Stochastic Oscillator
- NVS 63.41
- HSBC 45.72
About NVS Novartis AG
Novartis develops and manufactures innovative drugs. Key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States comprising close to one third of total revenue.
About HSBC HSBC Holdings plc.
Established in 1865 in Hong Kong, London-based HSBC is one of the largest banks in the world, with assets of USD 3 trillion and 40 million customers worldwide. It operates in around 60 countries with more than 200,000 full-time staff. The United Kingdom and Hong Kong are its two largest markets. The bank offers retail, commercial and institutional banking, global banking and markets, wealth management, and private banking.